United States · Who invested in Meissa Vaccines?
Meissa Vaccines's investors include Morningside Ventures.
2020
$3.4MSeed$30MSeries A
United States · Series A startup
Who invested in Meissa Vaccines
Funding summaryUpdated 26 Oct 2026
$33Mraised across 2 rounds since 2019, from 2 sources
$3.4MSeed$30MSeries A
- Latest round
- Series A, $30MSept 2019
- Step-upi
- 8.8×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed, $3.4M Mar 2019
- Biggest round
- $30M Series A · Sept 2019
- Between rounds
- 6 months from the last two
The rounds
- Sept 2019
- Mar 2019
Founders and team
From the SEC filings it signed: 2 on the team.
- Martin MooreExecutive Officer, Directori
- Roderick TangExecutive Officeri
On the board, as filediIsaac ChengKenneth KelleyStephanie O'BrienWilliam Daly
Quick answers about Meissa Vaccines
How much has Meissa Vaccines raised?
Meissa Vaccines has raised $33M across 2 rounds since 2019.
When did Meissa Vaccines last raise?
Meissa Vaccines's most recent round was a Series A of $30M in Sept 2019.
What was Meissa Vaccines's biggest round?
Its most recent round, $30M in Sept 2019, is also its largest on record.
Who backed Meissa Vaccines first?
Meissa Vaccines's first round on record, in Sept 2019, was backed by Morningside Ventures.
What stage is Meissa Vaccines at?
Meissa Vaccines's latest named round is a Series A, in Sept 2019.
Where is Meissa Vaccines based?
Meissa Vaccines is based in the United States.
Companies like Meissa Vaccines
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.